ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,017,000 | +72.4% | 11,320 | +1.8% | 0.01% | +100.0% |
| Q4 2019 | $590,000 | +12.4% | 11,120 | -16.4% | 0.00% | 0.0% |
| Q3 2019 | $525,000 | -4.0% | 13,300 | -0.0% | 0.00% | 0.0% |
| Q2 2019 | $547,000 | -29.8% | 13,305 | -20.5% | 0.00% | -25.0% |
| Q1 2019 | $779,000 | -9.7% | 16,730 | +10.9% | 0.00% | -20.0% |
| Q3 2018 | $863,000 | +1.5% | 15,080 | -13.9% | 0.01% | 0.0% |
| Q2 2018 | $850,000 | – | 17,520 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |